Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer
Clinical trial NCT03892642 · COMPLETED
Trial details
- NCT number
- NCT03892642
- Sponsor
- University of Oklahoma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-03-23
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.